|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$9.07 |
$9.14 |
$8.83 |
$9.01 |
457.40K | 03/22/2024 |
$9.05 |
$9.08 |
$8.64 |
$8.81 |
257.50K | 03/25/2024 |
$8.81 |
$8.98 |
$8.79 |
$8.93 |
297.70K | 03/26/2024 |
$9.34 |
$9.41 |
$8.49 |
$8.79 |
583.00K | 03/27/2024 |
$8.86 |
$9.08 |
$8.56 |
$8.85 |
426.50K |
|
Marinus Pharmaceuticals is a pharmaceutical company focused on the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus. The U.S Food and Drug Administration approved the use of ZTALMY (ganaxolone) oral suspension for the treatment of seizures associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder in patients two years of age and older. Co. is developing ganaxolone in formulations for two different routes of administration: intravenous (IV) and oral. Ganaxolone is a synthetic analog of allopregnanolone, an endogenous neurosteroid. | |
|
Marinus Pharmaceuticals (MRNS) has the following price history information. Looking back at MRNS historical stock prices for the last five trading days, on March 21, 2024, MRNS opened at $9.07, traded as high as $9.14 and as low as $8.83, and closed at $9.01. Trading volume was a total of 457.40K shares. On March 22, 2024, MRNS opened at $9.05, traded as high as $9.08 and as low as $8.64, and closed at $8.81. Trading volume was a total of 257.50K shares. On March 25, 2024, MRNS opened at $8.81, traded as high as $8.98 and as low as $8.79, and closed at $8.93. Trading volume was a total of 297.70K shares. On March 26, 2024, MRNS opened at $9.34, traded as high as $9.41 and as low as $8.49, and closed at $8.79. Trading volume was a total of 583.00K shares. On March 27, 2024, MRNS opened at $8.86, traded as high as $9.08 and as low as $8.56, and closed at $8.85. Trading volume was a total of 426.50K shares.
MRNS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Marinus Pharmaceuticals shares, starting with a $10,000 purchase of MRNS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/01/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$32.00 |
|
End price/share: |
$8.85 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-72.34% |
|
Average Annual Total Return: |
-12.46% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,765.03 |
|
Years: |
9.66 |
|
|
|
Date |
Close |
03/21/2024 | $9.01 | 03/22/2024 | $8.81 | 03/25/2024 | $8.93 | 03/26/2024 | $8.79 | 03/27/2024 | $8.85 |
|
|